Improved prognosis of Takayasu arteritis over the past decade - comprehensive analysis of 106 patients -

Circulation Journal

Volumn 76, Issue 4, 2012, Pages 1004-1011

  Ohigashi, Hirokazu ^a   Haraguchi, Go ^a   Konishi, Masanori ^a   Tezuka, Daisuke ^a   Kamiishi, Tetsuo ^a   Ishihara, Takashi ^a   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

HLA B52; Immunosuppressive therapy; Takayasu arteritis

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; HLA B52 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AORTA ARCH SYNDROME; AORTA OCCLUSION; AORTA VALVE REGURGITATION; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG DOSE REDUCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HLA TYPING; HUMAN; HYPERTENSION; INCIDENCE; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDY; TUBERCULOSIS;

ADULT; AGE OF ONSET; AGED; AORTIC VALVE INSUFFICIENCY; ARTERIAL OCCLUSIVE DISEASES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; GLUCOCORTICOIDS; HLA-B52 ANTIGEN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREDNISOLONE; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TAKAYASU ARTERITIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES; YOUNG ADULT;

EID: 84858987432     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1108     Document Type: Article

References (30)

1. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994; 120: 919-929.
2. JCS Joint Working Group. Guideline for management of vasculitis syndrome (JCS 2008): Digest version. Circ J 2011; 75: 474-503.
3. Numano F, Okawara M, Inomata H, Kobayashi Y. Takayasu's arteritis. Lancet 2000; 356: 1023-1025.
4. Mishima Y. Leriche Memorial Lecture at 24th World Congress: Takayasu's arteritis in Asia. Cardiovasc Surg 2001; 9: 3-10.
5. Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, et al; Itaka Study Group. Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum 2005; 53: 100-107.
6. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: A review. J Clin Pathol 2002; 55: 481-486.
7. Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F. Clinical manifestations of Takayasu arteritis in India and Japan--new classification of angiographic findings. Angiology 1997; 48: 369-379.
8. Kitamura H, Kobayashi Y, Kimura A, Numano F. Association of clinical manifestations with HLA-B alleles in Takayasu arteritis. Int J Cardiol 1998; 66(Suppl 1): S121-S126.
9. Moriwaki R, Numano F. Takayasu arteritis: Follow-up studies for 20 years. Heart Vessels Suppl 1992; 7: 138-145.
10. Cong XL, Dai SM, Feng X, Wang ZW, Lu QS, Yuan LX, et al. Takayasu's arteritis: Clinical features and outcomes of 125 patients in China. Clin Rheumatol 2010; 29: 973-981.
11. Lee GY, Jang SY, Ko SM, Kim EK, Lee SH, Han H, et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: Analysis of 204 Korean patients at a single center. Int J Cardiol 2011 Feb 25 [Epub ahead of print].
12. Andrews J, Mason JC. Takayasu's arteritis-recent advances imaging offer promise. Rheumatology 2007; 46: 6-15.
13. Schmidt WA, Nerenheim A, Seipelt E, Poehls C, Gromnica-Ihle E. Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford) 2002; 41: 496-502.
14. Park JH, Chung JW, Lee KW, Park YB, Han MC. CT angiography of Takayasu arteritis: Comparison with conventional angiography. J Vasc Interv Radiol 1997; 8: 393-400.
15. Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS. Takayasu arteritis: Utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002; 46: 1634-1642.
16. 18F-FDG PET in characterizing disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004; 31: 627-634.
17. 18FFDG PET coregistered with enhanced CT. J Nucl Med 2005; 46: 917-922.
18. Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994; 37: 578-582.
19. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 2005; 17: 16-24.
20. Ito I. Medical treatment of Takayasu arteritis. Heart Vessels Suppl 1992; 7: 133-137.
21. Shinjo SK, Pereira RM, Tizziani VA, Radu AS, Levy-Neto M. Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol 2007; 26: 1871-1875.
22. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004; 50: 2296-2304.
23. Maffei S, Di Renzo M, Santoro S, Puccetti L, Pasqui AL. Refractory Takayasu arteritis successfully treated with infliximab. Eur Rev Med Pharmacol Sci 2009; 13: 63-65.
24. Kathleen MM, Tiffany MC, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 2007; 56: 1000-1009.
25. Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, et al. Takayasu's arteritis in Turkey: Clinical and angiographic features of 248 patients. Clin Exp Rheumatol 2009; 27(Suppl 52): S59-S64.
26. de Souza AW, Machado NP, Pereira VM, Arraes AE, Reis Neto ET, Mariz HA, et al. Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis. Circ J 2010; 74: 1236-1241.
27. Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y, et al. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 2008; 118: 2738-2747.
28. Fields CE, Bower TC, Cooper LT, Hoskin T, Noel AA, Panneton JM, et al. Takayasu's arteritis: Operative results and influence of disease activity. J Vasc Surg 2006; 43: 64-71.
29. Park MC, Lee SW, Park YB, Lee SK, Choi D, Shim WH. Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu's arteritis. Rheumatology (Oxford) 2006; 45: 600-605.
30. Qureshi MA, Martin Z, Greenberg RK. Endovascular management of patients with Takayasu arteritis: Stents versus stent grafts. Semin Vasc Surg 2011; 24: 44-52.